NEW YORK, May 11, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Puma Biotechnology, Inc. ("Puma Biotechnology") (NASDAQ:PBYI) between February 29, 2016 and May 4, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Central District of California. To get more information go to:
http://www.zlk.com/pslra-sb/puma-biotechnology-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) the Company did not anticipate that the U.S. Food and Drug Administration (“FDA”) would ultimately approve PB272 (“neratinib”) for the treatment of breast cancer; (ii) as such, Puma Biotechnology had overstated the drug’s approval prospects and/or commercial viability; and (iii) as a result, Puma Biotechnology’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Puma Biotechnology you have until July 7, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
U.S. Budget Airlines Seek $2.5 Billion Government Aid Amid Rising Jet Fuel Costs
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy
European Car Sales Surge in March as EV and Hybrid Demand Accelerates
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth 



